Core Points - Picard Medical, Inc. successfully closed its initial public offering (IPO) of 4,250,000 shares at a price of $4.00 per share, generating gross proceeds of $17 million before deductions [1] - The company has granted underwriters an option to purchase an additional 637,500 shares to cover over-allotments within 30 days of the offering [1] - The shares began trading on the NYSE American under the ticker symbol "PMI" on August 29, 2025 [1] Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is recognized as the leader in total artificial heart technology for patients with end-stage heart failure [5] - The SynCardia Total Artificial Heart (STAH) is the only commercially available artificial heart approved by both the FDA and Health Canada, with over 2,100 implants performed across 27 countries [5] - The STAH is noted for being the most widely used and extensively studied artificial heart globally [5]

Gemini, a cryptocurrency exchange led by the billionaire Winklevoss twins, seeks to raise as much as $316.7 million in its initial public offering as the latest crypto business in line for a US listing https://t.co/gpo5WAGhvb ...

Company Overview - Black Rock Coffee Bar is a high-growth operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by engaging baristas [5] - Founded in 2008 in Beaverton, Oregon, it has grown from a single 160 square foot coffee bar to one of the fastest growing beverage companies in the U.S. by revenue, with over 150 locations across seven states [5] Initial Public Offering (IPO) Details - Black Rock Coffee Bar announced the launch of its initial public offering of 14,705,882 shares of Class A common stock, with an expected price range of $16.00 to $18.00 per share [1] - The company plans to grant underwriters a 30-day option to purchase an additional 2,205,882 shares at the IPO price, less underwriting discounts and commissions [1] Listing Information - The Class A common stock is expected to be listed on the Nasdaq Global Market under the ticker symbol "BRCB" [2] - J.P. Morgan, Jefferies, Morgan Stanley, and Baird are acting as lead book-running managers for the offering, with Stifel and William Blair as additional book-running managers [2]

SMG Swiss Marketplace Group plans to list on SIX, in what would be Switzerland’s first major IPO in over a year https://t.co/zOPvSNzH6P ...

Rolls-Royce has held exploratory talks with advisers over funding options, including an initial public offering, for its small nuclear reactor unit, according to the Financial Times https://t.co/MyXFK8WXBK ...

Core Viewpoint - Eastern International Ltd. has successfully completed its initial public offering (IPO) by selling 1,600,000 ordinary shares at a price of $4.00 per share, raising gross proceeds of $6.4 million before expenses [1][3]. Company Overview - Eastern International Ltd. is a holding company incorporated in the Cayman Islands, providing domestic and cross-border professional logistic services through its wholly owned subsidiary, Suzhou TC-Link Logistics Co., Ltd. [6] - Suzhou TC-Link was established in 2006 and has obtained the ISO 9001 certificate for high-quality service, operating a network that covers key cities in mainland China, Hong Kong, Southeast Asia, and Central Asia [6]. IPO Details - The shares began trading on the Nasdaq Capital Market under the symbol "ELOG" on August 28, 2025 [2]. - The company has granted Maxim Group LLC a 45-day option to purchase an additional 240,000 shares at the offering price, representing 15% of the shares sold in the offering [2]. - Maxim Group LLC acted as the sole book-running manager for the offering, with FisherBroyles, LLP and Hunter Taubman Fischer & Li LLC serving as legal counsel [3]. Financial Information - The total gross proceeds from the offering amounted to $6.4 million, prior to deducting underwriting discounts and other related expenses [3]. - The offering was conducted under the company's Registration Statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission on August 27, 2025 [4].

Core Viewpoint - Picard Medical, Inc. has announced the pricing of its initial public offering (IPO), aiming to raise $17 million through the sale of 4,250,000 shares at $4.00 per share, with trading expected to commence on August 29, 2025 under the ticker symbol "PMI" [1][3]. Group 1: Offering Details - The IPO consists of 4,250,000 shares priced at $4.00 each, totaling gross proceeds of $17 million before expenses [1]. - Underwriters have an option to purchase an additional 637,500 shares within 30 days to cover over-allotments [1]. - The offering is being conducted on a firm commitment basis, with WestPark Capital, Inc. as the Lead Manager and Sole Bookrunner [2]. Group 2: Use of Proceeds - Proceeds from the IPO will support market expansion in China through a joint venture, fund research and development for new products, and enhance sales and marketing capabilities [3]. - The funds will also be used to repay debt and cover general operational expenses and working capital [3]. Group 3: Company Background - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which manufactures the SynCardia Total Artificial Heart (STAH), the only FDA and Health Canada approved total artificial heart [6]. - The STAH is the most widely used artificial heart globally, with over 2,100 implants performed in 27 countries [6].

Core Viewpoint - A.I.S. Resources Limited is conducting a non-brokered private placement of up to 5,000,000 common shares at a price of $0.03 per share, aiming to raise gross proceeds of $150,000 for general working capital [1]. Group 1: Private Placement Details - The closing of the private placement is subject to acceptance by the TSX Venture Exchange, and all securities issued will have a four-month hold period from the closing date under Canadian securities laws [2]. - Certain directors and officers may participate in the private placement, which is considered a related party transaction exempt from minority approval and formal valuation requirements [3]. - The private placement securities will not be registered under the U.S. Securities Act of 1933 and cannot be offered or sold in the United States without registration or an applicable exemption [4]. Group 2: Financial Reporting and Compliance - The company is providing a bi-weekly default status report due to a voluntary management cease trade order granted because it could not file its annual financial statements and management's discussion and analysis for the year ended March 31, 2025, within the required timeframe [5]. - The company was unable to complete the year-end audit on time due to insufficient funds, necessitating additional time to file the annual filings [6]. - The audit is substantially completed, and proceeds from the private placement will be partially used to complete the audit, with expectations to file annual filings by September 29, 2025 [7]. Group 3: Other Updates - Buda Juice LLC, in which A.I.S. Resources Limited holds a minority stake, filed a registration statement for an initial public offering on August 27, 2025 [9]. - A.I.S. Resources Limited focuses on natural resource opportunities, aiming to unlock value through early-stage project acquisitions and providing necessary support [11].

IPO Market - 加拿大顶级证券交易所今年只有一次首次公开募股 (IPO)[1] - 目前来看，这次 IPO 的表现并不理想 [1]

Company Strategy - Avanse is considering delaying its initial public offering [1] Market Trends - Demand for loans is slowing [1] External Factors - Stricter US visa rules are impacting loan demand [1]